Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Non-muscle-invasive Bladder Cancer Clinical Trials

8 recruiting trials for Non-muscle-invasive Bladder Cancer. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
8
Total Trials
8
Recruiting Now
0
Phase 3 Trials
8
Sponsors

Recruiting Trials

RECRUITINGPhase 2NCT06663137

Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC

This is a prospective, single-arm study evaluating the safety and efficacy of NDV01 KIT, a fixed-dose combination of gemcitabine HCl and docetaxel, administered via intravesical...

Sponsor: Relmada Therapeutics, Inc.Enrolling: 701 location
RECRUITINGPhase 2NCT05957757

RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression

This is a prospective, open, single-center clinical study of anti-HER2-ADC combined with PD-1 monoclonal antibody for bladder sparing treatment in non-muscular invasive bladder...

Sponsor: RenJi HospitalEnrolling: 201 location
RECRUITINGNCT06972771

Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer

Bladder cancer ranks as the fourth most common malignancy among males the United States . Approximately 75% of patients present with non-muscle-invasive bladder cancer (NMIBC)....

Sponsor: Yunnan Cancer HospitalEnrolling: 301 location
RECRUITINGNCT05790850

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

The PRIMER (Pre-Habilitation With Mindfulness and Exercise for Patients Undergoing Radical Cystectomy) trial is a pilot designed to estimate the feasibility of integrating a...

Sponsor: University of VirginiaEnrolling: 301 location
RECRUITINGNCT05002556

AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer

The AFU has set itself the task of setting up a register of medical practices in order to define possible improvements in the therapeutic management and follow-up of NMIBC. In...

Sponsor: Association Francaise d'UrologieEnrolling: 800020 locations
RECRUITINGPhase 4NCT05962541

Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder...

Background: In European Association of Urology (EAU) Guidelines, the vast majority of non-muscle-invasive bladder cancers (NMIBCs) undergo a primary transurethral resection of the...

Sponsor: University of Roma La SapienzaEnrolling: 3271 location
RECRUITINGPhase 2NCT05327647

A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer

This is a phase II randomized controlled clinical trial comparing standard induction BCG versus bicalutamide and standard induction BCG among patients with non-muscle invasive...

Sponsor: CHU de Quebec-Universite LavalEnrolling: 1607 locations
RECRUITINGNCT07494864

Effects of Microbiological and Immunological Factors on the Lower Urinary Tract

Millions of patients of all ages suffer worldwide from diverse urinary pathologies, such as lower urinary tract (LUT) dysfunction, bladder pain syndrome, urinary tract infections...

Sponsor: University of ZurichEnrolling: 8001 location